|
IL81898D0
|
|
Process for preparing 4-amino-5-hexenoic acid
|
|
CA1216299A
|
|
Process for preparing 4-amino-5-hexenoic acid
|
|
GB8408818D0
|
|
1,4-dihydropyridine derivatives
|
|
IL81898A
|
|
Process for preparing 4-amino-5-hexenoic acid
|
|
GB8311804D0
|
|
Treatment of seizure disorders and pharmaceutical compositions
|
|
GB8311803D0
|
|
Treatment of seizure disorders and pharmaceutical compositions
|
|
US4496588A
|
|
Method of treating psoriasis
|
|
GB8311234D0
|
|
Aminoalkadiene derivative
|
|
GB2133002A
|
|
Process for preparing 4-amino-5-hexenoic acid
|
|
IL67483D0
|
|
Pharmaceutical compositions containing tropyl and pseudotropyl alkylbenzoates for treatment of migraine and some new such esters
|
|
IL67480D0
|
|
Pseudotropyl halogenobenzoates,their preparation and pharmaceutical compositions containing them for treatment of migraine
|
|
PH18483A
|
|
Tropyl and pseudotropyl alkyl benzoates and their use in migraine treatment
|
|
ZA8209097B
|
|
Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
|
|
GB2132189A
|
|
Tropyl and pseudotropyl benzoates and their use in migraine treatment
|
|
JPS59106487A
|
|
Tropyl and pseudotropylalkylbenzoate derivatives and use forhemicrania therapy
|
|
GB2131794A
|
|
Treatment of migraine with n-alkyl-piperidinyl benzoate derivatives
|
|
CA1215714A
|
|
Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
|
|
EP0111607A1
|
|
Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
|
|
ZA8209098B
|
|
Pseudotropyl halogenobenzoates and their use in migraine treatment
|
|
CA1219266A
|
|
Pseudotropyl halogenobenzoates and their use in migraine treatment
|
